Not just a bit of ‘chemobrain’: Barriers persist to treating cancer-related cognitive impairmentUrgent need for a tailored screening panel for patients with CRCI, as typical formal neurocognitive testing was developed for very different situations. Three new generics pharmacists and physicians should know aboutGet the info you need on these new generics, part of our drug news roundup for April. NEW DRUG: Omlyclo Get the info you need on this new drug, part of our drug news roundup for April. NEW DRUG: Steqeyma/Steqeyma I.V. Get the info you need on this new drug, part of our drug news roundup for April. NEW DRUG: Niopeg Get the info you need on this new drug, part of our drug news roundup for April. Mifepristone availability in pharmacies has drastically changed abortion access for Canadians New study published in the CMAJ finds that 91% of those looking for an abortion have a local mifepristone-dispensing pharmacy or procedural provider. NEW DRUG: Ayvakyt Get the info you need on this new drug, part of our drug news roundup for April. NEW DRUG: Abilify Asimtufii Get the info you need on this new drug, part of our drug news roundup for April. NEW DRUG: Tibsovo, new oral anticancer agent Get the info you need on this new drug, part of our drug news roundup for April. NEW DRUG: Fruzaqla for metastatic colon cancer Get the info you need on this new drug, part of our drug news roundup for April. First Previous 14 15 16 17 18 Next Last
